PTEN and PI3K/AKT in non-small-cell lung cancer
C Pérez-Ramírez, M Cañadas-Garre… - …, 2015 - Taylor & Francis
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. In the
last years, the identification of activating EGFR mutations, conferring increased sensitivity …
last years, the identification of activating EGFR mutations, conferring increased sensitivity …
PTEN and PI3K/AKT in non-small-cell lung cancer.
C Pérez-Ramírez, M Cañadas-Garre… - …, 2015 - europepmc.org
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. In the
last years, the identification of activating EGFR mutations, conferring increased sensitivity …
last years, the identification of activating EGFR mutations, conferring increased sensitivity …
PTEN and PI3K/AKT in non-small-cell lung cancer
C Pérez-Ramírez, M Cañadas-Garre… - …, 2015 - search.proquest.com
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. In the
last years, the identification of activating EGFR mutations, conferring increased sensitivity …
last years, the identification of activating EGFR mutations, conferring increased sensitivity …
PTEN and PI3K/AKT in non-small-cell lung cancer
C Pérez-Ramírez, M Cañadas-Garre… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. In the
last years, the identification of activating EGFR mutations, conferring increased sensitivity …
last years, the identification of activating EGFR mutations, conferring increased sensitivity …
PTEN and PI3K/AKT in non-small-cell lung cancer
C Pérez-Ramírez, M Cañadas-Garre, MÁ Molina… - …, 2015 - cir.nii.ac.jp
抄録< jats: p> Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths
worldwide. In the last years, the identification of activating EGFR mutations, conferring …
worldwide. In the last years, the identification of activating EGFR mutations, conferring …